These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2097005)
1. How best to analyse new strategies in bone marrow transplantation. Gale RP; Horowitz MM Bone Marrow Transplant; 1990 Dec; 6(6):357-9. PubMed ID: 2097005 [No Abstract] [Full Text] [Related]
2. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial. Hirsch A; Nijveldt R; van der Vleuten PA; Biemond BJ; Doevendans PA; van Rossum AC; Tijssen JG; Zijlstra F; Piek JJ; Am Heart J; 2006 Sep; 152(3):434-41. PubMed ID: 16923409 [TBL] [Abstract][Full Text] [Related]
3. Report on the Fourth Consensus Conference on the Methodology of Clinical Trials with Anxiolytic Drugs. Angst J; Ansseau M; Bech P; Engel RR; Hippius H; Lader M; Lecrubier Y; Lingjaerde O; de Sousa MP; Rossi A Pharmacopsychiatry; 1993 Jan; 26(1):1-5. PubMed ID: 8104347 [No Abstract] [Full Text] [Related]
4. Total body irradiation with or without lung shielding for allogeneic bone marrow transplantation. Labar B; Bogdanić V; Nemet D; Vrtar M; Mrsić M Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():108. PubMed ID: 2697391 [No Abstract] [Full Text] [Related]
5. Response as an end point in treatment trials for acute GVHD. Pavletic SZ Bone Marrow Transplant; 2012 Feb; 47(2):161-3. PubMed ID: 22314205 [No Abstract] [Full Text] [Related]
6. The REPAIR-AMI and ASTAMI trials: cell isolation procedures. Egeland T; Brinchmann JE Eur Heart J; 2007 Sep; 28(17):2174-5; author reply 2175. PubMed ID: 17673446 [No Abstract] [Full Text] [Related]
7. Purging procedures for acute leukaemias in autologous BMT. Rizzoli V; Mangoni L; Carella AM; Coleselli P; Angrilli F; Alessandrino EP; Miniero A; Novarino A; Falda M; Mozzana R Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():77-80. PubMed ID: 2697443 [No Abstract] [Full Text] [Related]
8. The Gini coefficient as a measure for understanding accrual inequalities in multicenter clinical studies. Haidich AB; Ioannidis JP J Clin Epidemiol; 2004 Apr; 57(4):341-8. PubMed ID: 15135834 [TBL] [Abstract][Full Text] [Related]
9. Allogeneic bone marrow transplantation for leukemia. Butturini A; Gale RP Curr Opin Hematol; 1994 Nov; 1(6):402-5. PubMed ID: 9371313 [TBL] [Abstract][Full Text] [Related]
10. Eighth biannual report of the Cochrane Haematological Malignancies Group--focus on chronic lymphatic leukemia. Herbst C; Monsef I; Skötz N; Engert A; J Natl Cancer Inst; 2008 Aug; 100(15):E1. PubMed ID: 18664654 [No Abstract] [Full Text] [Related]
11. Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantation. Blume KG; Long GD; Negrin RS; Chao NJ; Kusnierz-Glaz C; Amylon MD Bone Marrow Transplant; 1994; 14 Suppl 4():S9-10. PubMed ID: 7728133 [TBL] [Abstract][Full Text] [Related]
12. Analysing multicentre competing risks data with a mixed proportional hazards model for the subdistribution. Katsahian S; Resche-Rigon M; Chevret S; Porcher R Stat Med; 2006 Dec; 25(24):4267-78. PubMed ID: 16960919 [TBL] [Abstract][Full Text] [Related]
13. Use of busulfan containing chemotherapy for conditioning patients with leukemia for bone marrow allografting. Tutschka PJ Bone Marrow Transplant; 1993; 12 Suppl 1():34-6. PubMed ID: 8374557 [No Abstract] [Full Text] [Related]
14. Role of autologous bone marrow transplantation in acute leukemia. Dicke KA; Evinger-Hodges MJ; Spinolo JA; Spencer V Haematol Blood Transfus; 1990; 33():667-74. PubMed ID: 2182458 [No Abstract] [Full Text] [Related]